Additional information
| Manufacturer | Merck KGaA |
|---|---|
| Einecs | 231-545-4 |
| Cas-No | 7631-86-9 |
| Composition | Silica |
| Quality | Ph.Eur., USP |
Back to shop
Parteck® SLC 500
€0.00
Description
Parteck® SLC – Enhancing Drug Solubility
Low solubility of your active pharmaceutical ingredient (API) is often the cause of poor bioavailability. To improve your formulation we have developed Parteck® SLC, an innovative silica drug carrier that was awarded the silver prize at the 2012 CPhI Pharma Awards. Parteck® SLC provides maximum load for maximum release, significantly increasing bioavailability of your API.
Benefits of Parteck® SLC:
- Enhances solubility of APIs
- Superior dissolution performance
- Unique pore structure and high surface area
- User-friendly particle properties
- Reliable supply chain and application support
Feasibility studies have proven Parteck® SLC’s outstanding performance both in vitro and in vivo. Parteck® SLC offers the opportunity to reformulate molecules and potentially extend the life cycle of a drug.
Our expert support team is here to help – from early development to production. We offer you feasibility studies on loading your API on the carrier Parteck® SLC, showing the dissolution performance and helping you with final tablet formulation.